Accelerated atherosclerosis in apolipoprotein E-deficient mice fed Western diets containing palm oil compared with extra virgin olive oils: A role for small, dense high-density lipoproteins

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages 372-382

  Arbonés Mainar, José M ^a   Navarro, María A ^a   Carnicer, Ricardo ^a   Guillén, Natalia ^a   Surra, Joaquín C ^a   Acín, Sergio ^a   Guzmán, Mario A ^a   Sarría, Alfonso J ^a   Arnal, Carmen ^a   Aguilera, María Paz ^b   Jiménez, Antonio ^b   Beltrán, Gabriel ^b   Uceda, Marino ^b   Osada, Jesús ^a  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b IFAPA CENTRO EL TORUÑO   (Spain)

Author keywords

Apolipoprotein; Atherosclerosis; Mice; Olive oil; Paraoxonase

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; OLIVE OIL; PALM OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CULTIVAR; DIET; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEMALE; HYPOTHESIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RANDOMIZATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; AORTA; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; FEMALE; MICE; PLANT OILS;

EID: 34948903342     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.11.010     Document Type: Article

References (64)

1. Keys A., Menotti A., Karvonen M.J., et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 124 (1986) 903-915
2. Willett W. Dietary fat and breast cancer. Toxicol Sci 52 (1999) 127-146
3. de Lorgeril M., Salen P., Martin J.L., et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99 (1999) 779-785
4. Trichopoulou A., Costacou T., Bamia C., and Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348 (2003) 2599-2608
5. Knoops K.T.B., de Groot L.C.P.G.M., Kromhout D., et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE Project. JAMA 292 (2004) 1433-1439
6. Perona J.S., Cabello-Moruno R., and Ruiz-Gutierrez V. The role of virgin olive oil components in the modulation of endothelial function. J Nutr Biochem 17 (2006) 429-445
7. Perez-Jimenez F. International conference on the healthy effect of virgin olive oil. Eur J Clin Invest 35 (2005) 421-424
8. Aguilera C.M., Mesa M.D., Ramirez-Tortosa M.C., et al. Sunflower oil does not protect against LDL oxidation as virgin olive oil does in patients with peripheral vascular disease. Clin Nutr 23 (2004) 673-681
9. Rodenas S., Rodriguez-Gil S., Merinero M.C., and Sanchez-Muñiz F.J. Dietary exchange of an olive oil and sunflower oil blend for extra virgin olive oil decreases the estimate cardiovascular risk and LDL and apolipoprotein AII concentrations in postmenopausal women. J Am Coll Nutr 24 (2005) 361-369
10. Perez-Jimenez F., Espino A., Lopez-Segura F., et al. Lipoprotein concentrations in normolipidemic males consuming oleic acid-rich diets from two different sources: olive oil and oleic acid-rich sunflower oil. Am J Clin Nutr 62 (1995) 769-775
11. Perona J.S., Canizares J., Montero E., et al. Virgin olive oil reduces blood pressure in hypertensive elderly subjects. Clin Nutr 23 (2004) 1113-1121
12. von Eckardstein A., Huang Y., and Assmann G. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol 5 (1994) 404-416
13. Assmann G., and Nofer J.-R. Atheroprotective effects of high-density lipoproteins. Annu Rev Med 54 (2003) 321-341
14. Tward A., Xia Y.R., Wang X.P., et al. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106 (2002) 484-490
15. Qin X., Swertfeger D.K., Zheng S., Hui D.Y., and Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol Heart Circ Physiol 274 (1998) H1836-H1840
16. Ostos M.A., Conconi M., Vergnes L., et al. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21 (2001) 1023-1028
17. Calleja L., Paris M.A., Paul A., et al. Low-cholesterol and high-fat diets reduce atherosclerotic lesion development in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 19 (1999) 2368-2375
18. Aguilera C.M., Mesa M.D., Ramirez-Tortosa M.C., Quiles J.L., and Gil A. Virgin olive and fish oils enhance the hepatic antioxidant defence system in atherosclerotic rabbits. Clin Nutr 22 (2003) 379-384
19. Acin S., Navarro M.A., Carnicer R., et al. Dietary cholesterol suppresses the ability of olive oil to delay the development of atherosclerotic lesions in apolipoprotein E knockout mice. Atherosclerosis 182 (2005) 17-28
20. Merkel M., Velez-Carrasco W., Hudgins L.C., and Breslow J.L. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient mice. PNAS 98 (2001) 13294-13299
21. Sarria A.J., Surra J.C., Acin S., et al. Understanding the role of dietary components on atherosclerosis using genetic engineered mouse models. Front Biosci 11 (2006) 955-967
22. Navarro M.A., Carpintero R., Acin S., et al. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation. Cytokine 31 (2005) 52-63
23. Arbones-Mainar J.M., Navarro M.A., Guzman M.A., et al. Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis 189 (2006) 318-327
24. Navab M., Hama S.Y., Hough G.P., et al. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res 42 (2001) 1308-1317
25. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
26. Arbones-Mainar J.M., Navarro M.A., Acin S., et al. Trans-10, cis-12- and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J Nutr 136 (2006) 353-359
27. Duverger N., Tremp G., Caillaud J.-M., et al. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 273 (1996) 966-968
28. Cohen R.D., Castellani L.W., Qiao J.-H., et al. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest 99 (1997) 1906-1916
29. Katan M.B., Zock P.L., and Mensink R.P. Effects of fats and fatty acids on blood lipids in humans: an overview. Am J Clin Nutr 60 (1994) 1017S-1022S
30. Mattson F., and Grundy S. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 26 (1985) 194-202
31. Mensink R.P., and Katan M.B. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 12 (1992) 911-919
32. Nielsen L.B., Leth-Espensen P., Nordestgaard B.G., et al. Replacement of dietary saturated fat with monounsaturated fat: effect on atherogenesis in cholesterol-fed rabbits clamped at the same plasma cholesterol level. Br J Nutr 74 (1995) 509-521
33. Asset G., Bauge E., Fruchart J.C., and Dallongeville J. Lack of triglyceride-lowering properties of fish oil in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21 (2001) 401-406
34. Fito M., Cladellas M., de la Torre R., et al. Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis 181 (2005) 149-158
35. Covas M.I., Nyyssonen K., Poulsen H.E., et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med 145 (2006) 333-341
36. Ruano J., Lopez-Miranda J., Fuentes F., et al. Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J Am Coll Cardiol 46 (2005) 1864-1868
37. Acin S., Navarro M.A., Arbones-Mainar J.M., et al. Hydroxytyrosol administration enhances atherosclerotic lesion development in apo E deficient mice. J Biochem (Tokyo) 140 (2006) 383-391
38. Acin S., Navarro M.A., Perona J.S., et al. Olive oil preparation determines the atherosclerotic protection in apolipoprotein E knockout mice. J Nutr Biochem 18 (2007) 418-424
39. Herrera M.D., Rodríguez-Rodríguez R., and Ruiz-Gutiérrez V. Functional properties of pentacyclic triterpenes contained in "Orujo" olive oil. Curr Nutr Food Sci 2 (2006) 45-50
40. Márquez-Martín A., De la Puerta-Vázquez R., Fernández-Arche A., and Ruiz-Gutiérrez V. Supressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages. Free Radic Res 40 (2006) 295-302
41. Kris-Etherton P.M., Pearson T.A., Wan Y., et al. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr 70 (1999) 1009-1015
42. Acín S, Navarro MA, Perona JS, et al. Microarray analysis of hepatic genes differentially expressed in the presence of the unsaponifiable fraction of olive oil in apolipoprotein E-deficient mice. Br J Nutr, in press.
43. Aviram M., Rosenblat M., Bisgaier C.L., et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101 (1998) 1581-1590
44. Navab M., Hama S.Y., Cooke C.J., et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res 41 (2000) 1481-1494
45. Navab M., Hama S.Y., Anantharamaiah G.M., et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res 41 (2000) 1495-1508
46. Barter P.J., Nicholls S., Rye K.-A., et al. Antiinflammatory properties of HDL. Circ Res 95 (2004) 764-772
47. Kratz M., Wahrburg U., von Eckardstein A., et al. Dietary mono- and polyunsaturated fatty acids similarly increase plasma apolipoprotein A-IV concentrations in healthy men and women. J Nutr 133 (2003) 1821-1825
48. Navarro M.A., Acin S., Carnicer R., et al. Response of ApoA-IV in pigs to long-term increased dietary oil intake and to the degree of unsaturation of the fatty acids. Br J Nutr 92 (2004) 763-769
49. Kronenberg F., Stuhlinger M., Trenkwalder E., et al. Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol 36 (2000) 751-757
50. Green P.H., Glickman R.M., Riley J.W., and Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 65 (1980) 911-919
51. Bisgaier C., Sachdev O., Megna L., and Glickman R. Distribution of apolipoprotein A-IV in human plasma. J Lipid Res 26 (1985) 11-25
52. Dieplinger H., Lobentanz E.M., Konig P., et al. Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease. Eur J Clin Invest 22 (1992) 166-174
53. Duverger N., Ghalim N., Ailhaud G., et al. Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid. Arterioscler Thromb 13 (1993) 126-132
54. von Eckardstein A., Huang Y., Wu S., et al. Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma. Arterioscler Thromb Vasc Biol 15 (1995) 1755-1763
55. Ezeh B., Haiman M., Alber H.F., et al. Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls. J Lipid Res 44 (2003) 1523-1529
56. Lagrost L., Gambert P., Boquillon M., and Lallemant C. Evidence for high density lipoproteins as the major apolipoprotein A-IV-containing fraction in normal human serum. J Lipid Res 30 (1989) 1525-1534
57. Malmendier C., Lontie J., Lagrost L., et al. In vivo metabolism of apolipoproteins A-IV and A-I associated with high density lipoprotein in normolipidemic subjects. J Lipid Res 32 (1991) 801-808
58. Asztalos B., Zhang W., Roheim P.S., and Wong L. Role of free apolipoprotein A-I in cholesterol efflux: formation of pre-{alpha}-migrating high-density lipoprotein particles. Arterioscler Thromb Vasc Biol 17 (1997) 1630-1636
59. Thorngate F.E., Yancey P.G., Kellner-Weibel G., et al. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression. J Lipid Res 44 (2003) 2331-2338
60. Kontush A., Chantepie S., and Chapman M.J. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 23 (2003) 1881-1888
61. Graham A., Hassall D.G., Rafique S., and Owen J.S. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Atherosclerosis 135 (1997) 193-204
62. Gowri M.S., Van der Westhuyzen D.R., Bridges S.R., and Anderson J.W. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. Arterioscler Thromb Vasc Biol 19 (1999) 2226-2233
63. Valabhji J., McColl A.J., Schachter M., et al. High-density lipoprotein composition and paraoxonase activity in Type I diabetes. Clin Sci (Lond) 101 (2001) 659-670
64. Schiavon R., Battaglia P., De Fanti E., et al. HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism. Clin Chim Acta 324 (2002) 39-44